CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Coffin Robert President & Chief R&D Officer | Sale | −5,737 | $14.59 | $84K | 1,796,197 |
| 2022-05-16 | Astley-Sparke Philip Chief Executive Officer | Sale | −9,632 | $14.59 | $141K | 1,401,080 |
| 2022-04-01 | Astley-Sparke Philip Chief Executive Officer | Grant or award | +70,000 | 1,410,712 | ||
| 2022-04-01 | Astley-Sparke Philip Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2022-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award | +26,250 | 1,801,934 | ||
| 2022-04-01 | Coffin Robert President & Chief R&D Officer | Grant or award · Employee Stock Option (right to buy) | +39,375 | 39,375 | ||
| 2022-04-01 | Franchi Jean M. Chief Financial Officer | Grant or award | +52,500 | 98,535 | ||
| 2022-04-01 | Franchi Jean M. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +78,750 | 78,750 | ||
| 2022-04-01 | Patel Sushil Chief Commercial Officer | Grant or award | +52,500 | 140,833 | ||
| 2022-04-01 | Patel Sushil Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +78,750 | 78,750 | ||
| 2022-04-01 | Lewis Tanya Chief Dev.Op Off | Grant or award | +52,500 | 125,833 | ||
| 2022-04-01 | Lewis Tanya Chief Dev.Op Off | Grant or award · Employee Stock Option (right to buy) | +78,750 | 78,750 | ||
| 2022-04-01 | Esposito Pamela Chief Business Officer | Grant or award | +22,750 | 232,909 | ||
| 2022-04-01 | Esposito Pamela Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +34,125 | 34,125 | ||
| 2022-04-01 | Love Colin Chief Operating Officer | Grant or award | +26,250 | 772,059 | ||
| 2022-04-01 | Love Colin Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +39,375 | 39,375 | ||
| 2022-04-01 | Rhodes Jason P Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2022-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2022-04-01 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2022-04-01 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +24,750 | 24,750 |
Page 10 of 19 · 365 trades